Your browser is no longer supported. Please, upgrade your browser.
JNJ Johnson & Johnson daily Stock Chart
Johnson & Johnson
IndexDJIA S&P500 P/E24.17 EPS (ttm)5.33 Insider Own0.06% Shs Outstand2.68B Perf Week-0.43%
Market Cap345.60B Forward P/E14.97 EPS next Y8.60 Insider Trans-24.17% Shs Float2.68B Perf Month0.41%
Income14.54B PEG3.15 EPS next Q1.95 Inst Own68.70% Short Float0.59% Perf Quarter-7.37%
Sales81.38B P/S4.25 EPS this Y-12.20% Inst Trans0.14% Short Ratio1.56 Perf Half Y1.71%
Book/sh24.09 P/B5.35 EPS next Y5.36% ROA1.00% Target Price145.50 Perf Year-13.06%
Cash/sh7.22 P/C17.85 EPS next 5Y7.67% ROE2.50% 52W Range118.62 - 148.99 Perf YTD-0.19%
Dividend3.60 P/FCF37.85 EPS past 5Y6.20% ROI15.10% 52W High-13.55% Beta0.67
Dividend %2.80% Quick Ratio1.40 Sales past 5Y2.60% Gross Margin66.50% 52W Low8.58% ATR3.05
Employees134000 Current Ratio1.70 Sales Q/Q3.60% Oper. Margin21.40% RSI (14)43.66 Volatility1.43% 2.01%
OptionableYes Debt/Eq0.48 EPS Q/Q4.90% Profit Margin1.90% Rel Volume0.91 Prev Close128.80
ShortableYes LT Debt/Eq0.46 EarningsJan 22 BMO Payout526.10% Avg Volume10.10M Price128.80
Recom- SMA200.54% SMA50-5.90% SMA200-2.54% Volume9,267,966 Change0.00%
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Jul-20-17Resumed Credit Suisse Outperform $148
Jul-05-17Reiterated Morgan Stanley Overweight $135 → $140
Jan-23-19 05:05PM  3 Top Healthcare Stocks to Buy in January Motley Fool
04:14PM  Could A Rumored Buyout Help Johnson & Johnson Catch Intuitive Surgical? Investor's Business Daily
02:33PM  Better Buy: Amgen vs. Johnson & Johnson Motley Fool
12:33PM  Tampa virtual reality firm to work with Johnson & Johnson for pilot program American City Business Journals
10:59AM  JNJ Beats, Offers Bleak Outlook: Health Care ETFs in Focus Zacks
09:34AM  Company News For Jan 23, 2019 Zacks
09:31AM  Is a Beat in Store for AbbVie (ABBV) This Earnings Season? Zacks
08:50AM  Analysts Stand By Johnson & Johnson Despite Earnings Pullback Benzinga
07:54AM  Stocks making the biggest moves premarket: Comcast, Walmart, IBM & more CNBC
07:48AM  J&J eyeing surgical robotics firm Auris Health - Bbg Reuters
06:32AM  Stocks to rise | Davos rolls on | Shutdown enters Day 33 CNBC
02:42AM  J&J eyeing surgical robotics firm Auris Health -Bbg Reuters
Jan-22-19 10:43PM  Johnson & Johnson (JNJ) Q4 2018 Earnings Conference Call Transcript Motley Fool
08:57PM  J&J's talc powder controversy won't be a 'major challenge... CNBC Videos
08:43PM  Edited Transcript of JNJ earnings conference call or presentation 22-Jan-19 1:30pm GMT Thomson Reuters StreetEvents
07:54PM  [$$] Another Reason to Worry About Johnson & Johnson The Wall Street Journal
07:54PM  [$$] Johnson & Johnson Expects Sales Growth to Slow The Wall Street Journal
07:10PM  J&J, U.S. states settle hip implant claims for $120 million Reuters
06:48PM  'Be careful about how much you sell' at these levels, war... CNBC Videos
06:32PM  Cramer warns, 'careful about how much you sell' at these ... CNBC Videos
06:11PM  'Be careful about how much you sell' at these levels, warns Jim Cramer CNBC
05:26PM  Abbott Laboratories Expected to Earn 81 cents a Share
05:21PM  J&J, U.S. states settle hip implant claims for $120 million Reuters
05:10PM  J&J, U.S. states settle hip implant claims for $120 mln Reuters
05:02PM  Johnson & Johnson Reports 4th-Quarter Financial Results
05:01PM  What Happened in the Stock Market Today Motley Fool
04:40PM  Arconic and Stanley Black and Decker slide while eBay leaps Associated Press
04:36PM  US STOCKS-Wall St drops as economic outlook, corporate forecasts sour Reuters
04:28PM  3 Things to Know at Market Close: Jamie Dimon's the King of Wall Street
04:24PM  Johnson & Johnson Tops Q4 Earnings Estimate, Sees 2019 Sales Near $81 Billion
04:17PM  J&J Predicts A Revenue Slowdown Prodding Biotech, Pharma Stocks To Dip Investor's Business Daily
04:06PM  Dow Sinks as Global Growth Warnings Rattle Wall Street, Nasdaq Tumbles Over 2%
03:59PM  Jim Cramer: What Are We to Make of Today's Market Decline?
02:58PM  How to Play Johnson & Johnson Now That Earnings Are Out
02:39PM  US STOCKS-Wall St ends 4-day rally as economic outlook, corporate forecasts sour Reuters
01:47PM  US STOCKS-Wall St drops over 1.5 percent as global growth worries resurface Reuters
01:38PM  My Greatest Concern About Procter & Gamble Heading Into Earnings
01:32PM  [$$] Johnson & Johnson Expects Sales Growth to Slow The Wall Street Journal
01:24PM  China's Weak Economic Data and News from EBay, IBM, Halliburton, & More Zacks
01:10PM  J&J forecasts disappointing 2019 sales, defends talc safety Reuters
01:10PM  [$$] Gryphon Buys Antiaging Skincare Brand From Johnson & Johnson The Wall Street Journal
01:08PM  Johnson & Johnson 2019 revenue forecast misses expectations Reuters
12:53PM  J&J forecasts disappointing 2019 sales, defends talc safety Reuters
12:30PM  Shutdown risks delaying FDA approval of potentially life-saving drugs and therapies CNBC
12:27PM  J&J, U.S. states settle hip implant claims for $120 mln Reuters
12:25PM  46 Attorneys General reach $120 million settlement with J&J over hip implants MarketWatch
12:24PM  Johnson & Johnson Shares Fall on Disappointing 2019 Outlook
12:19PM  Is Corbus Pharmaceuticals a Buy? Motley Fool
12:11PM  US STOCKS-Wall St slips on global growth fears, weak corporate forecasts Reuters
12:03PM  [$$] Another Reason to Worry About Johnson & Johnson The Wall Street Journal
12:01PM  Johnson & Johnson puts up strong profit and revenue in 4Q Associated Press
11:33AM  Jim Cramer Says That Earnings Could Give Johnson & Johnson a Band-Aid
11:31AM  J&J Sees Slowing 2019 Growth in a Warning to Health-Care Sector Bloomberg
11:24AM  Jim Cramer's High Expectations for Intel's Earnings Report
11:07AM  Two Sticking Points With Johnson & Johnson: Guidance and Litigation Expense
10:50AM  Johnson & Johnson Drops After 2019 Outlook Misses Estimates Bloomberg
10:44AM  Johnson & Johnson CFO breaks down earnings, talc powder c... CNBC Videos
10:34AM  Market Fears Chinese Economic Slowdown Zacks
10:22AM  Johnson & Johnson Falls on Weak Earnings Report
10:21AM  US STOCKS-Wall Street edges lower as global growth fears resurface Reuters
10:19AM  China Trade Reckoning Back in Focus, Plus Q4 Reports: JNJ, TRV, HAL Zacks
10:17AM  Dow components head in opposite directions after earnings, one more is on the way MarketWatch
10:16AM  Stocks Drop On Growth Concerns, But This Dow Jones Stock Upgraded Investor's Business Daily
10:03AM  Johnson & Johnson revenue spikes American City Business Journals
09:57AM  J&J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft Zacks
09:51AM  Jim Cramer on Johnson & Johnson, China and Earnings
09:47AM  Stocks Open Lower: EBay Leads, Starbucks Partners With Uber Investor's Business Daily
09:33AM  Stock market opens lower on renewed global growth worries MarketWatch
09:23AM  Johnson & Johnson: How the Stock Looks on the Charts After Earnings
09:12AM  Johnson & Johnson 2019 revenue forecast misses expectations Reuters
09:10AM  US STOCKS-Wall St set to open lower as global growth fears resurface Reuters
09:07AM  Slowing Growth Worries Johnson & Johnson Shareholders Motley Fool
09:05AM  [$$] Stocks to Watch: Arconic, eBay, Facebook, Micron The Wall Street Journal
09:01AM  Stock Futures Drop: eBay Rockets, Dow Jones Stock Gets Upgrade Investor's Business Daily
08:56AM  Arconic Stock Tumbles 26%, Johnson & Johnson Slips and 3 More Tuesday Morning Movers
07:52AM  [$$] Johnson & Johnson sales outlook misses expectations Financial Times
07:49AM  Stocks making the biggest moves premarket: Johnson & Johnson, Nike, FedEx & more CNBC
07:48AM  US STOCKS-Futures lower on global growth worries after IMF trims outlook Reuters
07:16AM  Stocks to sink | Economic concerns hit Davos | Shutdown in Day 32 CNBC
07:01AM  IBM, Johnson & Johnson, Starbucks, Global Growth Worries- 5 Things You Must Know
06:53AM  Johnson & Johnson tops estimates for fourth quarter MarketWatch
06:41AM  Johnson & Johnson beats fourth-quarter earnings expectations CNBC
06:40AM  Johnson & Johnson Reports 2018 Fourth-Quarter Results: PR Newswire
06:14AM  Global Stocks Retreat on Growth Concerns; US Earnings Take Center Stage
Jan-21-19 02:08PM  AbbVie's Imbruvica Fails in Phase III Pancreatic Cancer Study Zacks
10:18AM  Private equity firms circling Nestle's skin health business - sources Reuters
10:04AM  Q4 2018 Earnings Reports in Focus Zacks
09:45AM  After MLK Day Today, Markets Go for 5 Straight Up Weeks Zacks
07:39AM  The Zacks Analyst Blog Highlights: Apple, Johnson & Johnson, Amazon and Alphabet Zacks
07:30AM  The 5 Big Earnings Reports Jim Cramer Will Be Watching This Week
Jan-20-19 02:02PM  3 Things to Watch in the Stock Market This Week Motley Fool
11:30AM  Better Buy: AbbVie vs. Johnson & Johnson Motley Fool
10:49AM  16 Stocks Jim Cramer Says Could Win from a U.S.-Chinese Trade Deal
Jan-19-19 01:00PM  3 Stocks You Don't Realize You Use Every Day Motley Fool
Jan-18-19 10:50PM  JOHNSON & JOHNSON INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Johnson & Johnson - JNJ PR Newswire
07:01PM  New Rules for This Market: Cramer's 'Mad Money' Recap (Friday 1/18/19)
06:27PM  Cramer's game plan: This week, forecasts are more importa... CNBC Videos
06:10PM  Cramer's game plan: This week, forecasts are more important than earnings CNBC
05:45PM  AbbVie's Imbruvica fails to meet main goal in pancreatic cancer study Reuters
05:10PM  What Happened in the Stock Market Today Motley Fool
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Its Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The company's Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, cardiovascular and metabolic, and pulmonary hypertension diseases. Its Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PRINCE CHARLESDirectorDec 14Buy134.372,000268,73128,520Dec 17 08:37 AM
MULCAHY ANNE MDirectorDec 14Buy133.76748100,0506,537Dec 17 08:37 AM
PEREZ WILLIAM DDirectorDec 14Buy133.911,000133,9109,122Dec 17 08:37 AM
Kapusta Ronald AController, CAODec 13Sale147.313,643536,63813,641Dec 14 04:33 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Option Exercise96.7341,5634,020,237119,890Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Sale146.6841,5636,096,55278,327Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Option Exercise94.12125,13211,777,919203,459Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Sale146.32125,13218,308,68978,327Dec 06 05:27 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Option Exercise58.3330,9431,804,90570,817Nov 27 06:56 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Sale142.4630,9434,407,98539,874Nov 27 06:56 PM
Gorsky AlexChairman, CEONov 16Option Exercise62.39264,46516,500,026601,024Nov 16 07:44 PM
Gorsky AlexChairman, CEONov 16Sale145.96264,46538,600,968336,559Nov 16 07:44 PM
Kapusta Ronald AController, CAONov 08Sale145.158,4411,225,20017,284Nov 09 05:22 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Option Exercise62.9440,0002,517,526133,555Nov 09 05:20 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Sale144.3640,0005,774,48093,555Nov 09 05:20 PM
Kapusta Ronald AController, CAOSep 07Sale137.187,8991,083,60725,725Sep 11 03:53 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Option Exercise58.3329,0001,691,57059,124Aug 28 04:03 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Sale134.8029,0003,909,08430,124Aug 28 04:03 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Option Exercise90.44155,34214,049,130357,906Feb 20 07:46 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Sale129.86155,34220,172,401202,564Feb 20 07:46 PM
Caruso Dominic JExec VP, Finance; CFOFeb 09Option Exercise0.0010,6010154,703Feb 13 06:54 PM
Duato JoaquinExec VP, WW Chair, PharmaFeb 09Option Exercise0.009,812078,348Feb 13 06:54 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 09Option Exercise0.005,830069,992Feb 13 06:54 PM
Gorsky AlexChairman, CEOFeb 09Option Exercise0.0033,1650285,990Feb 13 06:54 PM
PETERSON SANDRA EExec VP, Group WW ChairmanFeb 09Option Exercise0.0011,445070,205Feb 13 06:54 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 09Option Exercise0.0013,2520181,655Feb 13 06:55 PM
Ullmann Michael HExec VP, General CounselFeb 09Option Exercise0.005,9530115,257Feb 13 06:55 PM
Kapusta Ronald AController, CAOFeb 09Option Exercise0.002,702032,666Feb 13 06:55 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 02Option Exercise0.0032,688032,688Feb 06 04:21 PM